Skip to main content
. Author manuscript; available in PMC: 2024 Nov 1.
Published in final edited form as: Clin Pharmacol Ther. 2023 Aug 25;114(5):1050–1057. doi: 10.1002/cpt.3019

Table 4.

Sensitivity Analysis: 3:1 (Gabapentin:Duloxetine) Matched Analysis

Gabapentin
(N Prescriptions: 288,531)
Duloxetine
(N Prescriptions: 91,177)
Cox Proportional Hazards Analysis
Outcome Concurrent MME N Events Person-Years Rate per 1,000 person-years N Events Person-Years Rate per 1,000 person-years Hazard Ratio (95% CI)
All-Cause Mortality No MME (MME = 0) 243 22505 10.80 83 8051 10.31 1.06 (0.83, 1.36)
Low MME (MME >0 & MME < 50) 60 3698 16.22 20 1289 15.52 1.05 (0.63, 1.74)
High MME (MME ≥ 50) 25 2091 11.96 <11 744 9.40 1.30 (0.56, 3.01)
Out of Hospital Mortality No MME (MME = 0) 127 22402 5.67 34 8014 4.24 1.33 (0.91, 1.95)
Low MME (MME >0 & MME < 50) 40 3671 10.90 13 1281 10.15 1.07 (0.57, 2.00)
High MME (MME ≥ 50) 20 2076 9.63 <11 739 5.41 1.82 (0.62, 5.34)

CI=confidence interval, MME= Morphine Milligram Equivalents

Duloxetine is the reference for all Hazard Ratios